Home › Funds › Variant Private Wealth, LLC › JNJ

Variant Private Wealth, LLC position in JNJ

JOHNSON & JOHNSON · Health Care

Variant Private Wealth, LLC reported holding 981 shares of JNJ (JOHNSON & JOHNSON) in its Q2 2026 13F filing — a position valued at US$249K, representing 0.28% of its reported portfolio and ranking #38 among its reported holdings. Variant Private Wealth, LLC has disclosed JNJ holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)981 sh
Reported value held$249.11K
Portfolio Weight0.28%
First reportedQ3 2025
Last changeNew

How Variant Private Wealth, LLC's JNJ position evolved

Variant Private Wealth, LLC first disclosed a stake in JNJ in Q3 2025 at 1,181 shares (US$219K). The position peaked in Q2 2026 at 981 shares, worth US$249K. Across 4 filings, Variant Private Wealth, LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 981 shares valued at US$249K.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.18K $218.95K New
Q4 2025 1.15K $236.89K Reduce
Q1 2026 979 $239.36K Reduce
Q2 2026 981 $249.11K New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About JNJ and 13F data

JNJ (JOHNSON & JOHNSON) is a Health Care company. 33 other funds we track also report a position in JNJ — the largest reported positions include BlackRock Inc (US$53.87B), Vanguard Group (US$49.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$39.93B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding JNJ

All JNJ fund holders →